Flow cytometric analysis of MCF7 (Human breast adenocarcinoma epithelial cell, Left) / A172 (Human brain glioblastoma, Right) labelling Human CD325 antibody at 1/200 dilution (1 μg) / (Red) compared with a Mouse IgG1 (Black) Isotype control and an unlabelled control (cells without incubation with primary antibody and secondary antibody) (Blue). Goat Anti - Mouse IgG Alexa Fluor® 488 was used as the secondary antibody. Negative control: MCF7
Product Details
Product Details
Product Specification
Host | Mouse |
Antigen | CD325 |
Synonyms | Cadherin-2; CDw325; Neural cadherin (N-cadherin); CDHN; NCAD; CDH2 |
Location | Cell membrane |
Accession | P19022 |
Clone Number | S-2882 |
Antibody Type | Mouse mAb |
Isotype | IgG1,k |
Application | FCM |
Reactivity | Hu |
Positive Sample | A172 |
Purification | Protein G |
Concentration | 2 mg/ml |
Conjugation | Unconjugated |
Physical Appearance | Liquid |
Storage Buffer | PBS pH7.4 |
Stability & Storage | 12 months from date of receipt / reconstitution, 2 to 8 °C as supplied |
Dilution
application | dilution | species |
FCM | 1:200 | Hu |
Background
CD325, also known as N-cadherin or cadherin-2, is a 130–140 kDa type I transmembrane glycoprotein belonging to the cadherin superfamily. It is a calcium-dependent cell-cell adhesion molecule that plays a crucial role in maintaining tissue architecture and regulating morphogenetic movements during development. The protein consists of five extracellular cadherin repeats, a transmembrane region, and a highly conserved cytoplasmic tail. The extracellular domains mediate homophilic interactions between adjacent cells, while the cytoplasmic tail interacts with catenin proteins, which link the cadherin complex to the actin cytoskeleton. CD325 is expressed in various tissues, including neurons, cardiac muscle, and some cancer cells, and is involved in processes such as neural development, cardiac function, and cancer metastasis.
Picture
Picture
FC
